SRSF3 regulates DDX5 alternative splicing to promote Cervical cancer; MIR155HG binds SRSF1 to inhibit Cervical cancer progression; MicroRNA-802 and miR-1 targets SRSF9 to inhibit Cervical cancer progression. Here, DDX5 is linked to cervical cancer.